GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
Veru (VERU) stock has not been easy to own. The little biotech has spent years persuading investors that its experimental ...
Pharmaceutical Technology on MSN
Novo Nordisk puts AI at the centre of its clinical strategyNovo Nordisk’s Ibrahim Kamstrup-Akkaoui outlines how the Danish GLP-1 giant is embedding AI into its clinical foundation.
Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks ...
An analyst sees massive upside after the Novo Nordisk deal.
Tokyo, Japan and Cambridge, UK, 10 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”) announces that it has joined OpenFold, a ...
OpenAI has expanded GPT-Rosalind, its frontier reasoning model series for life sciences research, genomics, and drug discovery, for eligible research organizations, adding two domain plugins and ...
Some analysts are wondering whether the market can absorb the artificial intelligence giant’s planned stock offering — along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results